Overview
CompuGroup Medical SE & Co. KGaA, based in Koblenz, Germany, operates primarily in the healthcare informatics industry, providing comprehensive software and technology solutions aimed at enhancing healthcare services. The company specializes in electronic health records, practice management software, and e-health services, with a significant footprint in telemedicine and data analytics platforms. CompuGroup Medical's key projects typically focus on integrating digital health solutions across hospitals, pharmacies, and doctors' offices, thereby facilitating more efficient patient care and streamlined healthcare processes. The firm plays a crucial role in advancing digital transformation in healthcare, underpinning systems that support medical professionals worldwide to improve patient outcomes through better data management and accessibility.
AI+ Ask Fintel’s AI assistant about CompuGroup Medical SE & Co. KGaA.
Thinking about good questions…
Basic Stats
The Factor Analysis chart (below right) shows a view of CompuGroup Medical SE & Co. KGaA from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 51.73 MM |
| Earnings Date | |
| EPS (TTM) | 0.35 |
| Dividend Yield | |
| Ex-Dividend Date | 2025-08-04 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.01 |
| ROE | 0.03 |
| ROIC | 0.02 |
| CROIC | 0.00 |
| OCROIC | 0.10 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 7.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for CompuGroup Medical SE & Co. KGaA is € 65,01. The forecasts range from a low of € 46,46 to a high of € 85,05. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
| Record Date | Projection Date | High | Low | Median | Average |
|---|---|---|---|---|---|
| 2023-04-04 | 2024-04-04 | 85.05 | 46.46 | 66.30 | 65.01 |
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for CompuGroup Medical SE & Co. KGaA. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-12-14 | LANDESBANK BADEN-WUERTTEMBERG | Buy | Buy | Maintains |
| 2023-11-27 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-11-17 | BERENBERG | Hold | Hold | Maintains |
| 2023-11-10 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2023-11-10 | SRH ALSTERRESEARCH AG | Buy | Buy | Maintains |
| 2023-11-09 | STIFEL EUROPE | Buy | Buy | Maintains |
| 2023-11-09 | WARBURG RESEARCH GMBH | Buy | Buy | Maintains |
| 2023-08-23 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-08-22 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-08-22 | LANDESBANK BADEN-WUERTTEMBERG | Buy | Buy | Maintains |
| 2023-08-21 | LANDESBANK BADEN-WUERTTEMBERG | Buy | Buy | Maintains |
| 2023-08-11 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2023-08-11 | SRH ALSTERRESEARCH AG | Buy | Buy | Maintains |
| 2023-08-11 | BERENBERG | Buy | Hold | Downgrade |
| 2023-08-10 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2023-08-10 | SRH ALSTERRESEARCH AG | Buy | Buy | Maintains |
| 2023-08-10 | BERENBERG | Buy | Hold | Downgrade |
| 2023-08-10 | WARBURG RESEARCH GMBH | Buy | Buy | Maintains |
| 2023-08-09 | WARBURG RESEARCH GMBH | Buy | Buy | Maintains |
| 2023-05-26 | BERENBERG | Hold | Buy | Upgrade |
| 2019-11-07 | Baader Bank | Neutral | Initiate | |
| 2019-11-05 | HSBC | Neutral | Initiate | |
| 2019-11-05 | Deutsche Bank | Buy | Initiate | |
| 2023-05-25 | BERENBERG | Hold | Buy | Upgrade |
| 2023-05-24 | BNP PARIBAS EXANE | Neutral | Outperform | Upgrade |
| 2023-05-24 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2023-05-23 | BNP PARIBAS EXANE | Neutral | Outperform | Upgrade |
| 2023-05-23 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2023-05-15 | LANDESBANK BADEN-WUERTTEMBERG | Hold | Buy | Upgrade |
| 2023-05-14 | LANDESBANK BADEN-WUERTTEMBERG | Hold | Buy | Upgrade |
| 2023-05-11 | SRH ALSTERRESEARCH AG | Hold | Buy | Upgrade |
| 2023-05-10 | SRH ALSTERRESEARCH AG | Hold | Buy | Upgrade |
| 2023-05-10 | BRYAN GARNIER | Neutral | Buy | Upgrade |
| 2022-10-25 | BNP PARIBAS EXANE | Neutral | Neutral | Maintains |
| 2022-10-13 | ODDO BHF | Buy | Buy | Maintains |
| 2022-10-12 | ODDO BHF | Buy | Buy | Maintains |
| 2022-01-19 | BRYAN GARNIER | Buy | Neutral | Downgrade |
| 2023-05-10 | WARBURG RESEARCH GMBH | Buy | Buy | Maintains |
| 2023-05-09 | BRYAN GARNIER | Neutral | Buy | Upgrade |
| 2023-05-09 | WARBURG RESEARCH GMBH | Buy | Buy | Maintains |
| 2023-03-31 | BNP PARIBAS EXANE | Neutral | Outperform | Upgrade |
| 2023-03-31 | LANDESBANK BADEN-WUERTTEMBERG | Hold | Buy | Upgrade |
| 2023-03-29 | SRH ALSTERRESEARCH AG | Hold | Buy | Upgrade |
| 2023-02-14 | STIFEL EUROPE | Buy | Buy | Maintains |
| 2022-10-26 | BNP PARIBAS EXANE | Neutral | Neutral | Maintains |
| 2022-01-18 | BRYAN GARNIER | Buy | Neutral | Downgrade |
| 2022-01-18 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2022-01-17 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2021-09-15 | SRH ALSTERRESEARCH AG | Hold | Hold | Maintains |
| 2021-09-15 | WARBURG RESEARCH GMBH | Hold | Buy | Upgrade |
| 2021-09-15 | WARBURG RESEARCH GMBH | Buy | Buy | Maintains |
| 2021-09-14 | SRH ALSTERRESEARCH AG | Hold | Hold | Maintains |
| 2021-09-14 | WARBURG RESEARCH GMBH | Buy | Buy | Maintains |
| 2021-09-07 | LANDESBANK BADEN-WUERTTEMBERG | Buy | Hold | Downgrade |
| 2021-09-06 | LANDESBANK BADEN-WUERTTEMBERG | Buy | Hold | Downgrade |
| 2021-08-05 | BRYAN GARNIER | Buy | Buy | Maintains |
| 2021-08-04 | BRYAN GARNIER | Buy | Buy | Maintains |
| 2021-07-23 | LANDESBANK BADEN-WUERTTEMBERG | Hold | Buy | Upgrade |
| 2021-07-22 | LANDESBANK BADEN-WUERTTEMBERG | Hold | Buy | Upgrade |
| 2021-06-02 | Baader Bank | Sell | Initiate | |
| 2021-05-21 | Baader Bank | Sell | Initiate | |
| 2021-05-11 | Berenberg Bank | Buy | Initiate | |
| 2021-05-07 | Kepler Cheuvreux | Neutral | Initiate | |
| 2021-03-16 | Warburg Research | Buy | Initiate | |
| 2021-03-09 | LANDESBANK BADEN-WUERTTEMBERG | Hold | Hold | Maintains |
| 2021-03-08 | LANDESBANK BADEN-WUERTTEMBERG | Hold | Hold | Maintains |
| 2021-03-02 | COMMERZBANK CORPORATE CLIENTS | Hold | Hold | Maintains |
| 2021-03-01 | COMMERZBANK CORPORATE CLIENTS | Hold | Hold | Maintains |
| 2021-02-16 | BERENBERG | Hold | Hold | Maintains |
| 2021-02-15 | BERENBERG | Hold | Hold | Maintains |
| 2021-02-04 | WARBURG RESEARCH GMBH | Hold | Hold | Maintains |
| 2021-01-29 | Deutsche Bank | Buy | Initiate | |
| 2020-12-09 | Deutsche Bank | Buy | Initiate | |
| 2020-12-09 | Berenberg Bank | Neutral | Initiate | |
| 2020-12-08 | Baader Bank | Sell | Initiate | |
| 2020-12-08 | Warburg Research | Neutral | Initiate | |
| 2020-05-13 | Baader Bank | Sell | Initiate | |
| 2020-05-07 | Warburg Research | Buy | Initiate | |
| 2020-03-31 | Berenberg Bank | Buy | Initiate | |
| 2020-03-03 | Baader Bank | Buy | Initiate | |
| 2020-02-18 | Warburg Research | Buy | Initiate | |
| 2020-02-06 | Warburg Research | Neutral | Initiate | |
| 2020-02-05 | Baader Bank | Sell | Initiate | |
| 2020-01-30 | Warburg Research | Neutral | Initiate | |
| 2020-01-29 | Berenberg Bank | Neutral | Initiate | |
| 2019-11-08 | Warburg Research | Neutral | Initiate | |
| 2023-02-13 | STIFEL EUROPE | Buy | Buy | Maintains |
| 2023-02-10 | BERENBERG | Hold | Buy | Upgrade |
| 2023-02-10 | WARBURG RESEARCH GMBH | Buy | Buy | Maintains |
| 2023-02-09 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2023-02-09 | BRYAN GARNIER | Neutral | Buy | Upgrade |
| 2024-07-31 | WARBURG RESEARCH GMBH | Buy | Buy | Maintains |
| 2024-07-23 | BNP PARIBAS EXANE | Outperform | Neutral | Downgrade |
| 2024-07-14 | MWB RESEARCH AG | Buy | Buy | Maintains |
| 2024-07-10 | LANDESBANK BADEN-WUERTTEMBERG | Buy | Buy | Maintains |
| 2024-07-10 | BERENBERG | Hold | Buy | Upgrade |
| 2024-07-09 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2024-05-07 | STIFEL EUROPE | Buy | Buy | Maintains |
| 2024-01-23 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2024-01-02 | BERENBERG | Hold | Hold | Maintains |
| 2023-12-13 | LANDESBANK BADEN-WUERTTEMBERG | Buy | Buy | Maintains |
| 2023-11-26 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-11-16 | BERENBERG | Hold | Hold | Maintains |
| 2023-11-09 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2023-11-09 | SRH ALSTERRESEARCH AG | Buy | Buy | Maintains |
| 2023-11-08 | STIFEL EUROPE | Buy | Buy | Maintains |
| 2023-11-08 | WARBURG RESEARCH GMBH | Buy | Buy | Maintains |
| 2024-12-09 | MWB RESEARCH AG | Buy | Buy | Maintains |
| 2024-12-09 | BERENBERG | Buy | Hold | Downgrade |
| 2024-12-08 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2024-12-08 | WARBURG RESEARCH GMBH | Buy | Buy | Maintains |
| 2024-11-27 | STIFEL EUROPE | Buy | Hold | Downgrade |
| 2024-11-13 | BNP PARIBAS EXANE | Neutral | Neutral | Maintains |
| 2024-11-10 | LANDESBANK BADEN-WUERTTEMBERG | Buy | Buy | Maintains |
| 2024-11-07 | BERENBERG | Buy | Buy | Maintains |
| 2025-03-31 | BERENBERG | Hold | Hold | Maintains |
| 2025-03-30 | LANDESBANK BADEN-WUERTTEMBERG | Hold | Sell | Downgrade |
| 2025-03-17 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
| 2025-03-10 | LANDESBANK BADEN-WUERTTEMBERG | Buy | Hold | Downgrade |
| 2025-03-09 | MWB RESEARCH AG | Buy | Sell | Downgrade |
| 2025-03-05 | JEFFERIES | Hold | Hold | Maintains |
| 2025-07-14 | BAADER HELVEA EQUITY RESEARCH | Buy | Buy | Maintains |
